Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies

Submitted: 17 February 2014
Accepted: 17 February 2014
Published: 30 June 2008
Abstract Views: 901
PDF: 806
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We evaluated the correlation among four commercial ELISA tests for the presence of anti-Mycoplasma pneumoniae IgM antibodies in 36 samples obtained from patients with respiratory infections.The overall concordance among the four tests was 30%, while the one among single tests varies from 39% to 75%. Given the variability of the results, it is necessary to implement a External Quality Control specific for anti-Mycoplasma pneumoniae IgM antibodies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

De Paschale, M., Belvisi, L., Cagnin, D., Cerulli, T., Manco, M. T., Marinoni, L., Paganini, A., & Clerici, P. (2008). Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies. Microbiologia Medica, 23(2). https://doi.org/10.4081/mm.2008.2584